Europe PMCopen access
Mosquito salivary protein antibodies as efficient endpoints for vector control trials: A mechanistic comparison with clinical and entomological outcomes
Statistical analysis, Vector-borne Diseases, Mosquito Bites, Mechanistic Modeling, Clinical Trials Design, Mosquito Salivary Proteins
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253533
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.